5661 DAN (Sulindac 150 mg)
Pill imprint 5661 DAN has been identified as Sulindac 150 mg.
Sulindac is used in the treatment of pain; osteoarthritis; ankylosing spondylitis; familial adenomatous polyposis; bursitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 5661 DAN
- Strength:
- 150 mg
- Color:
- Yellow
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-5661
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
stearic acid
corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 66267-0264 | Nucare Pharmaceuticals Inc (repackager) |
| 54868-0879 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about sulindac
Consumer resources
- Other brands: Clinoril
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
